Brief: Phio Pharmaceuticals Announces Reverse Stock Split
25/01/2023 13:41
Jan 25 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT
* PHIO PHARMACEUTICALS CORP - BOARD OF DIRECTORS HAS
APPROVED A
REVERSE STOCK SPLIT OF ITS SHARES OF COMMON STOCK AT A RATIO OF
1-FOR-12
* PHIO PHARMACEUTICALS - COMMON STOCK WILL OPEN FOR TRADING
ON
NASDAQ CAPITAL MARKET ON POST-SPLIT BASIS ON JAN 26, UNDER CO'S
EXISTING TRADING SYMBOL
Source text for Eikon: ID:nPn9Kxn9qa
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing